Evolt is Going Public
We're preparing to go public on the ASX. Explore our financials, vision, and how to be part of our journey transforming global health through cutting-edge bioelectrical impedance technology.
Key Milestones Leading to ASX Announcement
Milestone One
Initial preparations and planning are underway for our upcoming ASX announcement.
Milestone Two
Finalizing documentation and compliance checks to ensure a smooth announcement process.
Milestone Three
Engaging with stakeholders to share our vision and strategy ahead of the announcement.
Announcement Day
Join us as we unveil exciting news that will shape the future of Evolt.
Company Snapshot
Key facts about Evolt Health's IPO journey
Financial Highlights
Essential details about Evolt's upcoming public listing
Revenue Growth
Annual Recurring Revenue
Customer Retention
Active Scans/Month
ASX Announcements
Prospectus Filed with ASX
Official IPO prospectus submitted to Australian Securities Exchange
Series C Funding Completed
$45M raised from leading HealthTech investors
Q1 2025 Results Announced
Record quarter with 95% revenue growth and 1M+ new scans
Unlock New Opportunities with Evolt's ASX Listing
Evolt's ASX listing opens doors to increased visibility and access to capital. Investors can expect enhanced growth potential and a commitment to innovation in wellness.
Gain early access to a thriving market.
Join us in shaping the future of health.
Experience the benefits of connected health solutions.
.avif)
Proven & Celebrated.
Our Awards.
